National Center for Environmental Health/Agency for Toxic Substances and Disease Registry, 19002-19003 [E7-7188]

Download as PDF 19002 Federal Register / Vol. 72, No. 72 / Monday, April 16, 2007 / Notices sponsoring organization (if any) with the submission. Written submissions will be made publicly available on the NIEHS Web site as they are received (https://www.niehs.nih.gov/conferences/ od/cehr/report.htm). (NIEHS, P.O. Box 12233, MD B2–08, Research Triangle Park, NC 27709; telephone: 919–541–5021 or e-mail: thayer@niehs.nih.gov). SUPPLEMENTARY INFORMATION: Background Information Over the past 30 years, the NIEHS has invested millions of dollars in children’s environmental health research. In order to maximize the effectiveness of current and future investments of human and financial resources, the Institute is conducting a review of the children’s environmental health programs. For the past eight years, the Institute has partnered with the EPA to support thirteen research centers devoted to children’s environmental health and disease prevention. The Children’s Centers draws upon the resources of community partners and the expertise of top universities and medical centers to focus on the important role that environmental toxicants play in the development of asthma, autism, and other childhood illnesses. The Children’s Centers are a prominent component of the research portfolio in children’s environmental health at both the NIEHS and EPA. As such, the NIEHS and EPA believe it is necessary to evaluate the program’s effectiveness as a mechanism to stimulate research in children’s environmental health. In addition, it is important to determine whether other approaches should be considered to advance children’s environmental health research and education. Supporting research that shows the greatest promise for rapidly identifying links between environmental exposures and childhood disorders and disease is a primary focus. cprice-sewell on PROD1PC66 with NOTICES Request for Comment At this time, the NIEHS seeks public comment on the working group report. The comments will be distributed to ORD and the NAEHS Council prior to discussion of the working group report at a public meeting on May 30–31, 2007. Comments or additional information may be submitted at any time; however, to ensure adequate time for consideration prior to the May 30–31, 2007 meeting, comments should be submitted by May 15, 2007. The NIEHS and the EPA will not respond to submitted comments; however, all comments will be considered by the NAEHS Council, NIEHS and the EPA in evaluating the best approaches for future funding of children’s environmental health research. Persons submitting comments should include their name, affiliation (if relevant), and VerDate Aug<31>2005 15:24 Apr 13, 2007 Jkt 211001 Dated: April 9, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–7184 Filed 4–13–07; 8:45 am] Dated: April 5, 2007. Samuel H. Wilson, Deputy Director, National Institute of Environmental Health Sciences and National Toxicology Program. [FR Doc. E7–7107 Filed 4–13–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4140–01–P Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES National Center for Environmental Health/Agency for Toxic Substances and Disease Registry Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: CDC Mentored Public Health Research Scientist Development Award, Request for Applications (RFA) CD07–003 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting of the aforementioned Special Emphasis Panel. Times and Dates: 8 a.m.–5 p.m., June 21, 2007 (Closed). 8 a.m.–5 p.m., June 22, 2007 (Closed). Place: Doubletree Buckhead Hotel, 3342 Peachtree Road, NE., Atlanta, GA 30326. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of the scientific merit of research applications in response to RFA CD07–003, ‘‘CDC Mentored Public Health Research Scientist Development Award.’’ Contact Person for More Information: Juliana Cyril, M.P.H., Ph.D., Designated Federal Officer, 1600 Clifton Road, Mailstop D72, Atlanta, GA 30333, telephone (404) 639–4639. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 The Community and Tribal Subcommittee of the Board of Scientific Counselors (BSC), Centers for Disease Control and Prevention (CDC), National Center for Environmental Health (NCEH)/Agency for Toxic Substances and Disease Registry (ATSDR): Meeting. In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention, NCEH/ATSDR announces the following meeting of the aforementioned subcommittee: Time and Date: 8:30 a.m.–4:30 p.m., May 16, 2007. Place: Century Center, 1825 Century Boulevard, Atlanta, Georgia 30345. Status: Open to the public, limited by the available space. The meeting room accommodates approximately 40 people. Purpose: Under the charge of the BSC, NCEH/ATSDR the CTS will provide the BSC, NCEH/ATSDR with a forum for community and tribal firsthand perspectives on the interactions and impacts of the NCEH/ATSDR’s national and regional policies, practices and programs. Matters To Be Discussed: The meeting agenda will include an update on NCEH/ATSDR Environmental Justice Web site development, a discussion on the Center’s Environmental Justice oriented inventory, a review and selection of projects for further discussion, and an update on the Office of Tribal Affairs. Items are subject to change as priorities dictate. SUPPLEMENTARY INFORMATION: This meeting is scheduled to begin at 8:30 a.m. Eastern Daylight Saving Time. To participate, please dial 877/315–6535 and enter conference code 383520. Public comment period is scheduled for 1:30 p.m.–1:45 p.m. Contact Person for More Information: Sandra Malcom, Committee Management Specialist, NCEH/ATSDR, E:\FR\FM\16APN1.SGM 16APN1 Federal Register / Vol. 72, No. 72 / Monday, April 16, 2007 / Notices 1600 Clifton Road, Mail Stop E–28, Atlanta, GA 30303, telephone: 404/498– 0003, fax: 404/498–0059, E-mail: smalcom@cdc.gov. The deadline for notification of attendance is May 2, 2007. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 9, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–7188 Filed 4–13–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Michael O. Leavitt, Secretary. [FR Doc. 07–1871 Filed 4–13–07; 8:45 am] Centers for Medicare and Medicaid Services BILLING CODE 4120–03–M cprice-sewell on PROD1PC66 with NOTICES Delegation of Authority Notice is hereby given that I have delegated to the Administrator of the Centers for Medicare and Medicaid Services, the following authority vested in the Secretary of Health and Human Services. Subpoenas for the Health Insurance Portability and Accountability Act of 1996 (HIPAA): Authority under Section 205(d) of the Social Security Act (42 U.S.C. 405(d)), with authority to redelegate, to issue subpoenas requiring the attendance and testimony of witnesses and the production of any evidence that relates to any matter under investigation or compliance review for failure to comply with the Health Insurance Portability and Accountability Act of 1996 (HIPAA) standards and requirements related at 45 CFR parts 160, 162 and 164 (except to the extent they pertain to the standards for privacy of individually identifiable health information). Section 1176(a)(2) of the Social Security Act, 42 U.S.C. 1320d–5(a)(2), which provides authority for the imposition of civil money penalties (CMPs) for violations, makes section 1128A of the Social Security Act, 42 U.S.C. 1320a–7a, applicable to the imposition of CMPs for violations of HIPAA administrative simplification standards. Section 1128A(j)(1), 42 U.S.C. 1320a–7a(j)(l), makes section 205(d) and (e) of the Social Security Act, 42 U.S.C. 405(d) and (e), applicable to section 1128A as the subsections are VerDate Aug<31>2005 15:24 Apr 13, 2007 Jkt 211001 with respect to Title II of the Social Security Act. Section 205(d) and (e) authorizes the issuance of subpoenas requiring the attendance and testimony of witnesses and the production of any evidence that relates to any matter under investigation by the Secretary and the enforcement of such a subpoena in court in event of refusal to comply. This delegation shall be exercised under the Department’s existing delegation of authority on the issuance of regulations and existing policy on the issuance of regulations. In addition, I hereby affirm and ratify any actions taken by the Administrator of the Centers for Medicare and Medicaid Services, or his subordinates which involved the exercise of the authority delegated herein prior to the effective date of this delegation. This delegation is effective immediately. DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Vaccines and Related Biological Products Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). At least one portion of the meeting will be closed to the public. Name of Committee: Vaccines and Related Biological Products Advisory Committee. General Function of the Committee: To provide advice and recommendations to the agency on FDA’s regulatory issues. Date and Time: The meeting will be held on May 16, 2007, from 9 a.m. to 4:30 p.m. and on May 17, 2007, from 8 a.m. to 1 p.m. Location: Hilton Hotel, Washington DC North/Gaithersburg, 620 Perry Pkwy., Gaithersburg, MD 20877. Contact Person: Christine Walsh or Denise Royster, Center for Biologics Evaluation and Research (HFM–71), Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852, 301–827–0314, or FDA Advisory Committee Information Line, 1–800– 741–8138 (301–443–0572 in the PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 19003 Washington, DC area), code 3014512391. Please call the Information Line for up-to-date information on this meeting. Agenda: On May 16, 2007, in the morning session, the committee will hear presentations and make recommendations on the safety and effectiveness of influenza virus vaccine live (FluMist) in a pediatric population less than 59 months of age, manufactured by MedImmune Vaccines, Inc. In the afternoon, the committee will hear an overview of the function of the Laboratory of Bacterial Polysaccharides and the Laboratory of Enteric & Sexually Transmitted Diseases, Division of Bacterial Parasitic and Allergenic Products, Office of Vaccines Research and Review, CBER and in closed session will discuss the report of the November 29, 2006, laboratory site visit. On May 17, 2007, the committee will hear presentations and make recommendations on the safety and immunogenicity of a live vaccinia virus smallpox vaccine (ACAM2000) manufactured by Acambis, Inc. FDA intends to make background material available to the public no later than 1 business day before the meeting. If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on FDA’s Web site after the meeting. Background material is available at https://www.fda.gov/ohrms/ dockets/ac/acmenu.htm, click on the year 2007 and scroll down to the appropriate advisory committee link. Procedure: On May 16, 2007, from 9 a.m. to 3:50 p.m. and on May 17, 2007, from 8 a.m. to 1 p.m., the meeting is open to the public. Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person on or before May 2, 2007. Oral presentations from the public will be scheduled between approximately 11:45 a.m. to 12:15 p.m. and 3:20 p.m. to 3:50 p.m. on May 16, 2007, and between approximately 11:15 a.m. to 11:45 a.m. on May 17, 2007. Those desiring to make formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before April 24, 2007. Time allotted for each presentation may be limited. If the number of registrants requesting to E:\FR\FM\16APN1.SGM 16APN1

Agencies

[Federal Register Volume 72, Number 72 (Monday, April 16, 2007)]
[Notices]
[Pages 19002-19003]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-7188]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Center for Environmental Health/Agency for Toxic 
Substances and Disease Registry

    The Community and Tribal Subcommittee of the Board of Scientific 
Counselors (BSC), Centers for Disease Control and Prevention (CDC), 
National Center for Environmental Health (NCEH)/Agency for Toxic 
Substances and Disease Registry (ATSDR): Meeting.
    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention, NCEH/ATSDR announces the following meeting of the 
aforementioned subcommittee:
    Time and Date: 8:30 a.m.-4:30 p.m., May 16, 2007.
    Place: Century Center, 1825 Century Boulevard, Atlanta, Georgia 
30345.
    Status: Open to the public, limited by the available space. The 
meeting room accommodates approximately 40 people.
    Purpose: Under the charge of the BSC, NCEH/ATSDR the CTS will 
provide the BSC, NCEH/ATSDR with a forum for community and tribal 
firsthand perspectives on the interactions and impacts of the NCEH/
ATSDR's national and regional policies, practices and programs.
    Matters To Be Discussed: The meeting agenda will include an update 
on NCEH/ATSDR Environmental Justice Web site development, a discussion 
on the Center's Environmental Justice oriented inventory, a review and 
selection of projects for further discussion, and an update on the 
Office of Tribal Affairs.
    Items are subject to change as priorities dictate.

SUPPLEMENTARY INFORMATION: This meeting is scheduled to begin at 8:30 
a.m. Eastern Daylight Saving Time. To participate, please dial 877/315-
6535 and enter conference code 383520. Public comment period is 
scheduled for 1:30 p.m.-1:45 p.m.
    Contact Person for More Information: Sandra Malcom, Committee 
Management Specialist, NCEH/ATSDR,

[[Page 19003]]

1600 Clifton Road, Mail Stop E-28, Atlanta, GA 30303, telephone: 404/
498-0003, fax: 404/498-0059, E-mail: smalcom@cdc.gov. The deadline for 
notification of attendance is May 2, 2007.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: April 9, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E7-7188 Filed 4-13-07; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.